Your catalyst for
Strategic Partnership
Proventa International is a management consulting company, specialising in life sciences business development services, with a truly global reach.
Unique experiences
We’re committed to delivering long-term value across our extensive life science network. Through our carefully crafted meetings, collaborative experiences and services Proventa International can offer you the perfect opportunity to meet your business goals, whatever they may be.
Whether you’re seeking answers to the industry’s biggest challenges, investing in new innovations or hoping to identify your next key partnership – Proventa International can help you get there.
Drug Discovery
Our events and services provide the ideal opportunity for pharmaceuticals, biotech and service providers to take the next step in the drug development process.
Strategy Meetings
Intimate format events where senior leadership discuss the biggest challenges facing the industry.
Overview
Investment
Helping launch the next generation of life-changing medicines. Meet the investors hoping to make a difference.
Overview
Consulting
Meet those hard to reach clients, no matter where they are. Personalised services in every corner of the globe.
OverviewPharmaFeatures provides thought-leading interviews, industry reports and innovative daily content on the newest trends and breaking news across life sciences. In addition to clients within the pharmaceutical space, PharmaFeatures tailors to readers in biotechnology, clinical research, bioinformatics and more.
28th Nov 2022
28th Nov 2022
A Counterintuitive Rheology Sheds Light to Novel Cancer Mechanobiology
Research Teams of JHU’s Konstantopoulos and UPF’s Valverde collaborate to shed light on counterintuitive rheology of cancer cells.
Overview
25th Nov 2022
25th Nov 2022
Tinkering with Tankyrase Ushers a New Era of Pharmacologics
Inner workings of tankyrase uncovered by researchers, opening the door for possibly better and less harmful cancer treatments.
Overview
24th Nov 2022
24th Nov 2022
Determination of Nitrosylation’s Centrality to PCSK9 Inhibition Foreshadows Novel Anticholesterols
Hope for hypercholesterolemia treatment increases with novel pharmacologic discoveries on PCSK9 inhibition.
OverviewInterested? See for yourself
Take the first step and see where Proventa International can take you. Join one of our unique one-day strategy meetings.
